.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cipla
McKinsey
Argus Health
Deloitte
Harvard Business School
Fuji
Novartis
Queensland Health
Fish and Richardson

Generated: January 23, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Australia Patent: PP5831

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Mylan Pharms IncOLUX Eclobetasol propionateAEROSOL, FOAM;TOPICAL022013-001Jan 12, 2007AB2RXYesYes➤ Subscribe➤ SubscribeY
Aqua PharmsVERDESOdesonideAEROSOL, FOAM;TOPICAL021978-001Sep 19, 2006RXYesYes➤ Subscribe➤ SubscribeY
Bayer HlthcareFINACEA azelaic acidAEROSOL, FOAM;TOPICAL207071-001Jul 29, 2015RXYesYes➤ Subscribe➤ SubscribeY
Mylan Pharms IncOLUX Eclobetasol propionateAEROSOL, FOAM;TOPICAL022013-001Jan 12, 2007AB2RXYesYes➤ Subscribe➤ SubscribeY
Aqua PharmsVERDESOdesonideAEROSOL, FOAM;TOPICAL021978-001Sep 19, 2006RXYesYes➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist